Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Varian plans $250m share buy-back

This article was originally published in Clinica

Executive Summary

Radiotherapy specialist Varian Medical Systems is to repurchase $250m of its common stock under an accelerated share buy-back programme. The transaction will be funded primarily through the firm's revolving credit facility with Bank of America, which it has amended to increase borrowing capacity from $225m to $300m. Varian will receive approximately 3.8 million shares, or 85% of the shares to be repurchased based on its closing share price on 24 August ($55.20). The stock buy-back is Varian's second this year – it also repurchased $280m in shares in February (www.clinica.co.uk, 2 March 2011). The company recently reported third-quarter revenue growth of 12%, to $649.4m, driven by continued demand for newer products in its oncology systems and X-ray products units (www.clinica.co.uk, 28 July 2011). Net income was also up, at $98.6m, compared with $85.5m during last year's Q3. As of the end of the third quarter of fiscal year 2011, Varian had 119.1 million fully diluted shares outstanding.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097812

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel